Daclizumab is injected into the body in order to help facilitate acceptance of transplanted kidneys. This drug suppresses the normal functioning of the immune system so that the patient’s body doesn’t attempt to eliminate the foreign kidney from the body. It is also used on an experimental basis to help multiple sclerosis patients by suppressing the action of the immune system so that it can’t attack vital tissues and organs.
Patients who are on this drug are more prone to infectious illness since the drug interferes with the normal functioning of the immune system. Patients may suffer from fevers, chills and nausea as well as from congestion, pneumonia and other infectious diseases. Patients should only take this drug under the supervision of a doctor and should stay in the hospital while on this drug in order to catch and take care of infectious illnesses.